← All indications
Metabolic Syndrome
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
Drugs by status
Phase 4 trials (98)
- jowiseungcheung-tang
- ezetimibe
- metoprolol
- metformin
- vitamin d3
- enalapril
- vitamin c
- risperidone
- quetiapine
- garlic
- olmesartan
- moxonidine
- tacrolimus
- nebivolol
- losartan
- acetylcysteine
- atenolol
- semaglutide
- infliximab
- mesoglycan
- dolutegravir
- ethinyl estradiol
- irbesartan
- eplerenone
- lamivudine
- inulin
- amlodipine
- crocus
- triptorelin
- somatropin
- +68 more
Phase 3 trials (41)
- sodium chloride
- ivy gourd fruit extract
- coffee
- cellulose
- flax
- glimepiride
- sofosbuvir
- lactobacillus helveticus
- exenatide
- agave
- vitamin e
- chromium tripicolinate
- phytosterol
- arginine
- tenofovir
- cnidoscolus chayamansa
- doravirine
- genistein
- elbasvir
- acarbose
- glycine
- aloe vera
- Emblica Officinalis
- nwt-03
- chungkookjang
- rimonabant
- coleus forskohlii extract
- biotin
- resveratrol
- astragalus membranaceus
- +11 more
Phase 2 trials (73)
- nigella sativa
- 3-v bioscience-2640
- ellagic acid
- aramchol
- gardenia jasminoides ellis
- prebiotic fiber
- metreleptin
- gymnema sylvestre
- cherry
- fiber
- ubiquinone
- rifaximin
- alpha-lipoic acid
- pear
- pyridoxine
- eprodisate
- lisinopril
- acacia
- chloroquine
- ursolic acid
- sieyesbeckiaorientalis
- spermidine
- insulin human
- Hesperedin
- salvia
- melatonin
- leucine
- ly-518674
- banana
- sodelglitazar
- +43 more
Phase 1 trials (24)
Other trials (159)
- docosahexaenoic acid
- magnesium citrate
- gynostemma pentaphyllum
- ginger
- pectin
- pasteurized a. muciniphila
- corn
- bithionol
- tocotrienol
- rye
- oleuropein
- phyllanthus
- orange juice
- carbamazepine
- inositol
- aspartame
- verbena
- morus nigra
- ketone
- sulforaphane
- sunflower oil
- rye kernel
- l-epigallocatechin
- cinnamon
- medroxyprogesterone
- guar gum
- spinach
- mastiha oil
- fenugreek seed
- cheddar cheese
- +129 more
Organizations
Organization Involved with Phase 4 Indications (124)
- Abbott
- Daiichi Sankyo
- Takeda
- Bristol-Myers Squibb
- Gilead Sciences
- AstraZeneca
- Merck
- Novo Nordisk
- Eli Lilly
- Pfizer
- Sanofi
- Novartis
- Atlanta Heart Specialists, LLC
- Bayer
- GlaxoSmithKline
- HeartDrug Research LLC
- JW Pharmaceutical
- Kos Pharmaceuticals
- Solvay
- Boehringer Ingelheim
- Otsuka
- Veterans Medical Research Foundation
- National Institutes of Health (NIH)
- National Center for Research Resources (NCRR)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Mental Health (NIMH)
- University of Roma La Sapienza
- University of Pennsylvania
- Maastricht University
- +94 more
Organization Involved with Phase 3 Indications (73)
- Catalysis SL
- DSM
- GWT-TUD GmbH
- Kobe University
- Newtricious R&D BV
- Olive Lifesciences Pvt Ltd
- Aultman Health Foundation
- Medical Research Foundation, The Netherlands
- British Columbia Cancer Agency
- National Nutrition and Food Technology Institute
- University Hospital, Basel, Switzerland
- Roquette Freres
- Huazhong University of Science and Technology
- University of Manitoba
- Ain Shams University
- Bambino Gesù Hospital and Research Institute
- Canadian Urologic Oncology Group
- Georgetown University
- LanZhou University
- McMaster University
- Mercy Medical Center
- Russian Academy of Medical Sciences
- Translational Research Institute for Metabolism and Diabetes, Florida
- Universidad Autonoma de Nuevo Leon
- Universidad de Colima
- University of Guelph
- University of Hamburg
- University of Messina
- University of Milan
- University of Regensburg
- +43 more
Organization Involved with Phase 2 Indications (90)
- Sagimet Biosciences
- Medicure
- Amgen
- Merck Serono
- Bellus Health Inc
- Biosearch S.A.
- Chiesi
- Exalenz Bioscience LTD.
- Galmed Pharmaceuticals Ltd
- Laboratorios Silanes S.A. de C.V.
- ProMetic Life Sciences
- Torrent Pharmaceuticals Limited
- Rottapharm
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Neurological Disorders and Stroke (NINDS)
- United States Department of Agriculture
- Western Sydney Local Health District
- World Health Organization
- Rockefeller University
- Alborz Medical University
- Cornell University
- Emory University
- Florida State University
- Hillel Yaffe Medical Center
- Hospital Juarez de Mexico
- Hospital Mateo Orfila
- Instituto Nacional de Cardiologia Ignacio Chavez
- Johns Hopkins University
- Queen's University, Belfast
- +60 more
Organization Involved with Phase 1 Indications (12)
Organization Involved with Other Experimental Indications (164)
- Pierre Fabre
- Algosource
- Schering-Plough
- Atrium Innovations
- Beneo GmbH
- Carmel Biosciences
- Danisco
- Danone Research
- DoubleGood AB
- Gateway Health Alliance
- Vedic Lifesciences Pvt. Ltd.
- Diabetes Foundation, India
- Midwest Biomedical Research Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- Central Institute of Psychiatry, Ranchi, India
- National Cancer Institute (NCI)
- National Institute on Aging (NIA)
- Swiss Federal Institute of Technology
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- MDM S.p.A.
- Region Skane
- Region Syddanmark
- Aarhus University
- Central South University
- Azad University
- Boston University
- Brown University
- Canadian Collaborative Research Network
- Central Hospital of Kanta-Hame
- Ege University
- +134 more